Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis

JAAD Case Rep. 2017 Jul 19;3(4):339-341. doi: 10.1016/j.jdcr.2017.03.008. eCollection 2017 Jul.

Authors

Laurel L Wessman¹, Elizabeth K Blixt², David A Wetter², Rachel Y Miest²

Affiliations

¹ University of North Dakota Medical School, Grand Forks, North Dakota.
² Department of Dermatology, Mayo Clinic, Rochester, Minnesota.

No abstract available

Keywords: Adalimumab; BP, bullous pemphigoid; TNF, tumor necrosis factor; bullous disease; drug reaction; ulcerative colitis.

Publication types

Case Reports